Medicine Man Technologies, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 46.75 million compared to USD 43.19 million a year ago. Net loss was USD 0.322462 million compared to net income of USD 1.81 million a year ago. Basic loss per share from continuing operations was USD 0.02. Diluted loss per share from continuing operations was USD 0.03.
For the nine months, revenue was USD 129.12 million compared to USD 119.23 million a year ago. Net loss was USD 5.18 million compared to net income of USD 8.87 million a year ago. Basic loss per share from continuing operations was USD 0.14 compared to basic earnings per share from continuing operations of USD 0.07 a year ago. Diluted loss per share from continuing operations was USD 0.14 compared to diluted earnings per share from continuing operations of USD 0.03 a year ago.